Inclusion Criteria:  patients who provide written and informed consent to participate patients whose calculated CHA2DS2-VASc score is ≥ 2  Exclusion Criteria:  subjects previously diagnosed with atrial fibrillation subjects implanted pacemaker, cardioverter-defibrillator, or any electrical devices subjects had skin problems such as allergic contact dermatitis female patients who are pregnant, or lactating status.